Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Aimmune Therapeutics, Inc. (AIMT) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Aimmune Therapeutics, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1631650.
Total stock buying since 2015: $2,298,261,933.
Total stock sales since 2015: $45,033,234.
Total stock option exercises since 2015: $5,918,461.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2020 | 55,775,586 | $2,136,840,957 | 28,240 | $714,840 | 91,420 | $1,298,838 |
| 2019 | 1,550 | $34,977 | 30,000 | $931,039 | 30,000 | $358,500 |
| 2018 | 4,247,747 | $130,308,230 | 478,697 | $15,974,872 | 478,697 | $1,899,393 |
| 2017 | 5,000 | $99,210 | 737,614 | $20,359,090 | 350,835 | $2,016,933 |
| 2016 | 235,512 | $3,255,480 | 404,096 | $7,053,393 | 114,096 | $344,797 |
| 2015 | 1,666,680 | $27,723,079 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2020-10 | 54,117,287 | $1,867,046,401 | 0 | $0 | 71,020 | $901,058 |
| 2020-05 | 0 | $0 | 7,840 | $0 | 0 | $0 |
| 2020-03 | 132,665 | $1,553,010 | 0 | $0 | 0 | $0 |
| 2020-02 | 1,525,634 | $268,241,546 | 0 | $0 | 0 | $0 |
| 2020-01 | 0 | $0 | 20,400 | $714,840 | 20,400 | $397,780 |
| 2019-12 | 0 | $0 | 30,000 | $931,039 | 30,000 | $358,500 |
| 2019-09 | 1,550 | $34,977 | 0 | $0 | 0 | $0 |
| 2018-11 | 3,241,179 | $98,100,592 | 40,000 | $1,201,600 | 40,000 | $120,879 |
| 2018-06 | 1,600 | $48,662 | 300,000 | $9,529,222 | 300,000 | $906,598 |
| 2018-05 | 0 | $0 | 3,296 | $108,768 | 3,296 | $42,683 |
| 2018-03 | 0 | $0 | 5,330 | $187,953 | 5,330 | $62,849 |
| 2018-02 | 1,004,968 | $32,158,976 | 8,240 | $291,573 | 8,240 | $41,262 |
| 2018-01 | 0 | $0 | 121,831 | $4,655,756 | 121,831 | $725,122 |
| 2017-12 | 0 | $0 | 82,074 | $3,205,920 | 82,074 | $325,758 |
| 2017-11 | 0 | $0 | 5,655 | $201,615 | 5,655 | $98,281 |
| 2017-10 | 0 | $0 | 257,425 | $8,113,611 | 57,425 | $887,053 |
| 2017-09 | 0 | $0 | 178,390 | $4,330,410 | 78,390 | $321,172 |
| 2017-07 | 0 | $0 | 139,070 | $2,943,643 | 81,610 | $246,623 |
| 2017-06 | 0 | $0 | 49,400 | $998,571 | 0 | $0 |
| 2017-05 | 5,000 | $99,210 | 600 | $12,090 | 0 | $0 |
| 2017-04 | 0 | $0 | 15,000 | $323,730 | 15,000 | $45,330 |
| 2017-03 | 0 | $0 | 10,000 | $229,500 | 10,000 | $30,219 |
| 2017-01 | 0 | $0 | 0 | $0 | 20,681 | $62,497 |
| 2016-11 | 0 | $0 | 109,096 | $2,474,673 | 59,096 | $178,587 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2020-10-13 | Societe Des Produits Nestle S.a. (10% Owner) | Buy | 54,117,287 | 34.50 | 1,867,046,401 |
| 2020-10-05 | Sheehy Douglas T. (See Remarks) | Option Ex | 30,888 | 12.95 | 399,999 |
| 2020-10-05 | Bjerkholt Eric (Chief Financial Officer) | Option Ex | 5,200 | 19.44 | 101,088 |
| 2020-10-02 | Adelman Daniel C Md (Chief Medical Officer) | Option Ex | 34,932 | 11.45 | 399,971 |
| 2020-05-27 | Enright Patrick G (Director) | Sale | 7,840 | .00 | 0 |
| 2020-03-18 | Enright Patrick G (Director) | Buy | 16,213 | 11.06 | 179,348 |
| 2020-03-17 | Enright Patrick G (Director) | Buy | 108,787 | 11.45 | 1,245,393 |
| 2020-03-13 | Oxtoby Andrew (Chief Commercial Officer) | Buy | 3,000 | 14.76 | 44,265 |
| 2020-03-12 | Bjerkholt Eric (Chief Financial Officer) | Buy | 1,000 | 15.10 | 15,100 |
| 2020-03-10 | Dallas Jayson Donald Alexander (President and CEO) | Buy | 2,665 | 18.74 | 49,934 |
| 2020-03-09 | Bjerkholt Eric (Chief Financial Officer) | Buy | 1,000 | 18.97 | 18,970 |
| 2020-02-07 | Nestle Sa (10% Owner) | Buy | 1,525,634 | 175.82 | 268,241,546 |
| 2020-01-16 | Sheehy Douglas T. (See Remarks) | Sale | 400 | 37.00 | 14,800 |
| 2020-01-16 | Sheehy Douglas T. (See Remarks) | Option Ex | 400 | 12.95 | 5,180 |
| 2020-01-02 | Adelman Daniel C Md (Chief Medical Officer) | Sale | 20,000 | 35.00 | 700,040 |
| 2020-01-02 | Adelman Daniel C Md (Chief Medical Officer) | Option Ex | 20,000 | 19.63 | 392,600 |
| 2019-12-26 | Sheehy Douglas T. (See Remarks) | Sale | 10,000 | 33.03 | 330,319 |
| 2019-12-26 | Sheehy Douglas T. (See Remarks) | Option Ex | 10,000 | 12.95 | 129,500 |
| 2019-12-09 | Adelman Daniel C Md (Chief Medical Officer) | Sale | 20,000 | 30.04 | 600,720 |
| 2019-12-09 | Adelman Daniel C Md (Chief Medical Officer) | Option Ex | 20,000 | 11.45 | 229,000 |
| 2019-09-18 | Bjerkholt Eric (Chief Financial Officer) | Buy | 1,550 | 22.57 | 34,977 |
| 2018-11-28 | Nimco Us, Inc. (10% Owner) | Buy | 3,237,529 | 30.27 | 98,000,002 |
| 2018-11-19 | Barrowcliffe Susan E. (General Manager, Europe) | Sale | 40,000 | 30.04 | 1,201,600 |
| 2018-11-19 | Barrowcliffe Susan E. (General Manager, Europe) | Option Ex | 40,000 | 3.02 | 120,879 |
| 2018-11-19 | Dallas Jayson Donald Alexander (President and CEO) | Buy | 3,650 | 27.56 | 100,590 |
| 2018-06-13 | Bjerkholt Eric (Chief Financial Officer) | Buy | 1,600 | 30.41 | 48,662 |
| 2018-06-11 | Dilly Stephen George (President and CEO) | Sale | 29,457 | 30.84 | 908,306 |
| 2018-06-11 | Dilly Stephen George (President and CEO) | Option Ex | 29,457 | 3.02 | 89,019 |
| 2018-06-08 | Dilly Stephen George (President and CEO) | Sale | 42,106 | 30.70 | 1,292,527 |
| 2018-06-08 | Dilly Stephen George (President and CEO) | Option Ex | 42,106 | 3.02 | 127,244 |
| 2018-06-07 | Dilly Stephen George (President and CEO) | Sale | 32,598 | 31.26 | 1,019,111 |
| 2018-06-07 | Dilly Stephen George (President and CEO) | Option Ex | 32,598 | 3.02 | 98,511 |
| 2018-06-06 | Dilly Stephen George (President and CEO) | Sale | 30,465 | 31.20 | 950,386 |
| 2018-06-06 | Dilly Stephen George (President and CEO) | Option Ex | 30,465 | 3.02 | 92,065 |
| 2018-06-05 | Dilly Stephen George (See Remarks) | Sale | 38,825 | 31.83 | 1,235,838 |
| 2018-06-05 | Dilly Stephen George (See Remarks) | Option Ex | 38,825 | 3.02 | 117,329 |
| 2018-06-04 | Dilly Stephen George (See Remarks) | Sale | 65,352 | 32.29 | 2,110,346 |
| 2018-06-04 | Dilly Stephen George (See Remarks) | Option Ex | 65,352 | 3.02 | 197,493 |
| 2018-06-01 | Dilly Stephen George (See Remarks) | Sale | 61,197 | 32.89 | 2,012,708 |
| 2018-06-01 | Dilly Stephen George (See Remarks) | Option Ex | 61,197 | 3.02 | 184,937 |
| 2018-05-22 | Sheehy Douglas T. (See Remarks) | Sale | 3,296 | 33.00 | 108,768 |
| 2018-05-22 | Sheehy Douglas T. (See Remarks) | Option Ex | 3,296 | 12.95 | 42,683 |
| 2018-03-05 | Sheehy Douglas T. (See Remarks) | Sale | 3,523 | 36.37 | 128,142 |
| 2018-03-05 | Sheehy Douglas T. (See Remarks) | Option Ex | 3,523 | 16.29 | 57,389 |
| 2018-03-01 | Rozenman Mary M. (See Remarks) | Sale | 1,807 | 33.10 | 59,811 |
| 2018-03-01 | Rozenman Mary M. (See Remarks) | Option Ex | 1,807 | 3.02 | 5,460 |
| 2018-02-26 | Nimco Us, Inc. (10% Owner) | Buy | 937,500 | 32.00 | 30,000,000 |
| 2018-02-26 | Iwicki Mark T (Director) | Buy | 9,375 | 32.00 | 300,000 |
| 2018-02-26 | Falberg Kathryn E (Director) | Buy | 30,000 | 32.00 | 960,000 |
| 2018-02-26 | Bjerkholt Eric (Chief Financial Officer) | Buy | 3,125 | 32.00 | 100,000 |
| 2018-02-22 | Tammenoms Bakker Juliet (10% Owner) | Buy | 9,375 | 32.00 | 300,000 |
| 2018-02-22 | Enright Patrick G (Director) | Buy | 15,593 | 32.00 | 498,976 |
| 2018-02-05 | Sheehy Douglas T. (See Remarks) | Sale | 1,648 | 35.87 | 59,113 |
| 2018-02-05 | Sheehy Douglas T. (See Remarks) | Option Ex | 1,648 | 12.95 | 21,341 |
| 2018-02-01 | Rozenman Mary M. (See Remarks) | Sale | 6,592 | 35.26 | 232,460 |
| 2018-02-01 | Rozenman Mary M. (See Remarks) | Option Ex | 6,592 | 3.02 | 19,921 |
| 2018-01-24 | Sheehy Douglas T. (See Remarks) | Sale | 1,875 | 38.15 | 71,531 |
| 2018-01-24 | Sheehy Douglas T. (See Remarks) | Option Ex | 1,875 | 19.63 | 36,806 |
| 2018-01-16 | Adelman Daniel C Md (Chief Medical Officer) | Sale | 9,933 | 40.00 | 397,320 |
| 2018-01-16 | Adelman Daniel C Md (Chief Medical Officer) | Option Ex | 9,933 | 11.45 | 113,732 |
| 2018-01-12 | Adelman Daniel C Md (Chief Medical Officer) | Sale | 26,784 | 40.00 | 1,071,360 |
| 2018-01-12 | Adelman Daniel C Md (Chief Medical Officer) | Option Ex | 26,784 | 11.45 | 306,676 |
| 2018-01-04 | Sheehy Douglas T. (See Remarks) | Sale | 1,648 | 37.33 | 61,519 |
| 2018-01-04 | Sheehy Douglas T. (See Remarks) | Option Ex | 1,648 | 12.95 | 21,341 |
| 2018-01-02 | Barrowcliffe Susan E. (General Manager, Europe) | Sale | 75,000 | 37.46 | 2,809,500 |
| 2018-01-02 | Barrowcliffe Susan E. (General Manager, Europe) | Option Ex | 75,000 | 3.02 | 226,649 |
| 2018-01-02 | Rozenman Mary M. (See Remarks) | Sale | 6,591 | 37.10 | 244,526 |
| 2018-01-02 | Rozenman Mary M. (See Remarks) | Option Ex | 6,591 | 3.02 | 19,918 |
| 2017-12-27 | Adelman Daniel C Md (Chief Medical Officer) | Sale | 3,283 | 40.00 | 131,320 |
| 2017-12-27 | Adelman Daniel C Md (Chief Medical Officer) | Option Ex | 3,283 | 11.45 | 37,590 |
| 2017-12-26 | Rozenman Mary M. (See Remarks) | Sale | 75,010 | 39.02 | 2,926,965 |
| 2017-12-26 | Rozenman Mary M. (See Remarks) | Option Ex | 75,010 | 3.02 | 226,680 |
| 2017-12-26 | Sheehy Douglas T. (See Remarks) | Sale | 1,875 | 39.44 | 73,950 |
| 2017-12-26 | Sheehy Douglas T. (See Remarks) | Option Ex | 1,875 | 19.63 | 36,806 |
| 2017-12-04 | Sheehy Douglas T. (See Remarks) | Sale | 1,906 | 38.66 | 73,685 |
| 2017-12-04 | Sheehy Douglas T. (See Remarks) | Option Ex | 1,906 | 12.95 | 24,682 |
| 2017-11-30 | Sheehy Douglas T. (See Remarks) | Sale | 3,750 | 37.00 | 138,750 |
| 2017-11-30 | Sheehy Douglas T. (See Remarks) | Option Ex | 3,750 | 19.63 | 73,612 |
| 2017-11-09 | Sheehy Douglas T. (See Remarks) | Sale | 1,905 | 33.00 | 62,865 |
| 2017-11-09 | Sheehy Douglas T. (See Remarks) | Option Ex | 1,905 | 12.95 | 24,669 |
| 2017-10-23 | Sheehy Douglas T. (See Remarks) | Sale | 47,425 | 35.07 | 1,663,242 |
| 2017-10-23 | Sheehy Douglas T. (See Remarks) | Option Ex | 47,425 | 16.29 | 772,553 |
| 2017-10-23 | Dilly Stephen George (See Remarks) | Sale | 100,000 | 34.83 | 3,483,100 |
| 2017-10-23 | Adelman Daniel C Md (Chief Medical Officer) | Sale | 10,000 | 34.33 | 343,260 |
| 2017-10-23 | Adelman Daniel C Md (Chief Medical Officer) | Option Ex | 10,000 | 11.45 | 114,500 |
| 2017-10-16 | Dilly Stephen George (President and CEO) | Sale | 1,154 | 26.24 | 30,278 |
| 2017-10-06 | Dilly Stephen George (President and CEO) | Sale | 4,047 | 26.31 | 106,468 |
| 2017-10-05 | Dilly Stephen George (President and CEO) | Sale | 14,689 | 26.24 | 385,498 |
| 2017-10-04 | Dilly Stephen George (President and CEO) | Sale | 80,110 | 26.24 | 2,101,765 |
| 2017-09-25 | Barrowcliffe Susan E. (General Manager, Europe) | Sale | 20,000 | 25.00 | 500,000 |
| 2017-09-25 | Barrowcliffe Susan E. (General Manager, Europe) | Option Ex | 20,000 | 3.02 | 60,439 |
| 2017-09-25 | Dilly Stephen George (President and CEO) | Sale | 100,000 | 25.01 | 2,500,800 |
| 2017-09-25 | Adelman Daniel C Md (Chief Medical Officer) | Sale | 10,000 | 25.00 | 250,000 |
| 2017-09-25 | Adelman Daniel C Md (Chief Medical Officer) | Option Ex | 10,000 | 11.45 | 114,500 |
| 2017-09-07 | Rozenman Mary M. (See Remarks) | Sale | 30,000 | 22.50 | 675,000 |
| 2017-09-07 | Rozenman Mary M. (See Remarks) | Option Ex | 30,000 | 3.02 | 90,660 |
| 2017-09-06 | Barrowcliffe Susan E. (General Manager, Europe) | Sale | 15,167 | 22.00 | 333,704 |
| 2017-09-06 | Barrowcliffe Susan E. (General Manager, Europe) | Option Ex | 15,167 | 3.02 | 45,834 |
| 2017-09-05 | Barrowcliffe Susan E. (General Manager, Europe) | Sale | 3,223 | 22.00 | 70,906 |
| 2017-09-05 | Barrowcliffe Susan E. (General Manager, Europe) | Option Ex | 3,223 | 3.02 | 9,739 |
| 2017-07-27 | Barrowcliffe Susan E. (General Manager, Europe) | Sale | 500 | 22.00 | 11,000 |
| 2017-07-27 | Barrowcliffe Susan E. (General Manager, Europe) | Option Ex | 500 | 3.02 | 1,511 |
| 2017-07-26 | Dilly Stephen George (President and CEO) | Sale | 50,000 | 21.46 | 1,073,100 |
| 2017-07-25 | Barrowcliffe Susan E. (General Manager, Europe) | Sale | 4,650 | 22.00 | 102,300 |
| 2017-07-25 | Barrowcliffe Susan E. (General Manager, Europe) | Option Ex | 4,650 | 3.02 | 14,052 |
| 2017-07-24 | Barrowcliffe Susan E. (General Manager, Europe) | Sale | 500 | 22.00 | 11,000 |
| 2017-07-24 | Barrowcliffe Susan E. (General Manager, Europe) | Option Ex | 500 | 3.02 | 1,511 |
| 2017-07-21 | Barrowcliffe Susan E. (General Manager, Europe) | Sale | 960 | 22.00 | 21,120 |
| 2017-07-21 | Barrowcliffe Susan E. (General Manager, Europe) | Option Ex | 960 | 3.02 | 2,901 |
| 2017-07-21 | Sheehy Douglas T. (See Remarks) | Sale | 7,460 | 21.66 | 161,561 |
| 2017-07-17 | Rozenman Mary M. (See Remarks) | Sale | 300 | 21.38 | 6,414 |
| 2017-07-17 | Rozenman Mary M. (See Remarks) | Option Ex | 300 | 3.02 | 906 |
| 2017-07-14 | Rozenman Mary M. (See Remarks) | Sale | 5,666 | 21.39 | 121,173 |
| 2017-07-14 | Rozenman Mary M. (See Remarks) | Option Ex | 5,666 | 3.02 | 17,122 |
| 2017-07-13 | Rozenman Mary M. (See Remarks) | Sale | 8,974 | 21.47 | 192,662 |
| 2017-07-13 | Rozenman Mary M. (See Remarks) | Option Ex | 8,974 | 3.02 | 27,119 |
| 2017-07-05 | Rozenman Mary M. (See Remarks) | Sale | 15,060 | 21.39 | 322,208 |
| 2017-07-05 | Rozenman Mary M. (See Remarks) | Option Ex | 15,060 | 3.02 | 45,511 |
| 2017-07-03 | Barrowcliffe Susan E. (General Manager, Europe) | Sale | 15,000 | 20.26 | 303,915 |
| 2017-07-03 | Barrowcliffe Susan E. (General Manager, Europe) | Option Ex | 15,000 | 3.02 | 45,330 |
| 2017-07-03 | Rozenman Mary M. (See Remarks) | Sale | 30,000 | 20.57 | 617,190 |
| 2017-07-03 | Rozenman Mary M. (See Remarks) | Option Ex | 30,000 | 3.02 | 90,660 |
| 2017-06-23 | Dilly Stephen George (President and CEO) | Sale | 49,400 | 20.21 | 998,571 |
| 2017-05-12 | Bjerkholt Eric (Chief Financial Officer) | Buy | 5,000 | 19.84 | 99,210 |
| 2017-05-10 | Dilly Stephen George (See Remarks) | Sale | 600 | 20.15 | 12,090 |
| 2017-04-03 | Desouza Warren L. (Chief Financial Officer) | Sale | 15,000 | 21.58 | 323,730 |
| 2017-04-03 | Desouza Warren L. (Chief Financial Officer) | Option Ex | 15,000 | 3.02 | 45,330 |
| 2017-03-21 | Desouza Warren L. (Chief Financial Officer) | Sale | 10,000 | 22.95 | 229,500 |
| 2017-03-21 | Desouza Warren L. (Chief Financial Officer) | Option Ex | 10,000 | 3.02 | 30,219 |
| 2017-01-11 | Desouza Warren L. (Chief Financial Officer) | Option Ex | 20,681 | 3.02 | 62,497 |
| 2016-11-11 | Barrowcliffe Susan E. (General Manager, Europe) | Sale | 20,000 | 25.00 | 500,000 |
| 2016-11-11 | Barrowcliffe Susan E. (General Manager, Europe) | Option Ex | 20,000 | 3.02 | 60,439 |
| 2016-11-11 | Dilly Stephen George (See Remarks) | Sale | 48,696 | 25.01 | 1,217,984 |
| 2016-11-10 | Dilly Stephen George (See Remarks) | Sale | 1,304 | 25.00 | 32,600 |
| 2016-11-08 | Barrowcliffe Susan E. (General Manager, Europe) | Sale | 15,000 | 20.00 | 300,000 |
| 2016-11-08 | Barrowcliffe Susan E. (General Manager, Europe) | Option Ex | 15,000 | 3.02 | 45,330 |
| 2016-11-04 | Rozenman Mary M. (See Remarks) | Sale | 24,096 | 17.60 | 424,089 |
| 2016-11-04 | Rozenman Mary M. (See Remarks) | Option Ex | 24,096 | 3.02 | 72,818 |
| 2016-10-05 | Rozenman Mary M. (See Remarks) | Sale | 25,000 | 16.80 | 420,000 |
| 2016-10-05 | Rozenman Mary M. (See Remarks) | Option Ex | 25,000 | 3.02 | 75,550 |
| 2016-09-08 | Rozenman Mary M. (See Remarks) | Sale | 30,000 | 16.80 | 504,000 |
| 2016-09-08 | Rozenman Mary M. (See Remarks) | Option Ex | 30,000 | 3.02 | 90,660 |
| 2016-05-31 | Tananbaum James B. (10% Owner) | Sale | 240,000 | 15.23 | 3,654,720 |
| 2016-03-29 | Enright Patrick G (Director) | Buy | 157,008 | 13.82 | 2,170,320 |
| 2015-08-24 | Tananbaum James B. (10% Owner) | Buy | 25,485 | 19.66 | 500,907 |
| 2015-08-11 | Tananbaum James B. (10% Owner) | Buy | 642,035 | 17.50 | 11,235,612 |
| 2015-08-11 | Iwicki Mark T (Director) | Buy | 20,000 | 16.00 | 320,000 |
| 2015-08-11 | Enright Patrick G (Director) | Buy | 625,000 | 16.00 | 10,000,000 |
| 2015-08-11 | Mcdade Mark (Director) | Buy | 16,660 | 16.00 | 266,560 |
| 2015-08-11 | Falberg Kathryn E (Director) | Buy | 25,000 | 16.00 | 400,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of AIMT listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Aimmune Therapeutics, Inc. (symbol AIMT, CIK number 1631650) see the Securities and Exchange Commission (SEC) website.